RecruitingNCT04998227
Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction
Sponsor
National Taiwan University Hospital
Enrollment
300 participants
Start Date
Apr 26, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The project is planed to explore the impact of LTBP4 and other matrix protein and potentially related biomarkers on renal outcomes, cardiac outcomes and all-cause mortality in patients with suspected acute coronary syndrome (ACS).
Eligibility
Min Age: 20 YearsMax Age: 80 Years
Inclusion Criteria1
- \- acute coronary syndrome patients
Exclusion Criteria1
- \- cardiogenic shock, pregnancy, end-stage renal disease
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04998227
Related Trials
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
NCT072582901 location
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
NCT046951061 location
Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS
NCT060141129 locations
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
NCT054735206 locations
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
NCT0710262860 locations